Open AccessConcomitant administration of lenvatinib and camrelizumab for the treatment of hepatocellular carcinoma, and its effect on hepatocellular carcinoma control
Author(s) -
Ruibao Liu,
Xiaolei Zhang,
Xing Wang
Publication year - 2022
Publication title -
tropical journal of pharmaceutical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.209
H-Index - 36
eISSN - 1596-5996
pISSN - 1596-9827
DOI - 10.4314/tjpr.v21i9.22
Subject(s) - lenvatinib , medicine , hepatocellular carcinoma , liver function , gastroenterology , alpha fetoprotein , oncology , concomitant , sorafenib